Raymond Perkins is a Respiratory physician. OpenAlex indexes 7 publications with 253 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
302 University Blvd
Round Rock, TX 786651032
Telephone
512-509-0200Provider last certified this registry record 6 Jan 2021.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202511 payments
- GlaxoSmithKline, LLC.Program year202515 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
36.4%Corticosteroid22.5%Trelegy Ellipta72%Breztri Aerosphere15%Breo Ellipta7%Budesonide-Formoterol Fumarate4%Fluticasone Propionate3%Part D<11 patientsbeta2-Adrenergic Agonist10.7%Albuterol Sulfate Hfa85%Ventolin Hfa15%Part D<11 patients+ 3 more classes in this area
Nervous system
36%Gabapentinoids7.8%Gabapentin89%Pregabalin11%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator5.9%Zolpidem Tartrate92%Zolpidem Tartrate Er8%Part D<11 patients+ 8 more classes in this area
Anti-infectives
16.3%Macrolide Antimicrobial16.3%Azithromycin100%Part D≥78 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Asbestos Upregulates Expression of the Urokinase-Type Plasminogen Activator Receptor on Mesothelial Cells
American Journal of Respiratory Cell and Molecular Biology
1999 - Human Alveolar Macrophage Cytokine Release in Response to in Vitro and in Vivo Asbestos Exposure
Experimental Lung Research
1993 - Effects of continuous high dose rhgm‐csf infusion on human monocyte activity
American Journal of Hematology
1993 - Bleomycin stimulation of cytokine secretion by the human alveolar macrophage
American Journal of Physiology-Lung Cellular and Molecular Physiology
1992 - <i>In Vitro</i> Bioactivity of Asbestos for the Human Alveolar Macrophage and its Modification by IgG
American Journal of Respiratory Cell and Molecular Biology
1991
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”